NRG Oncology NRG-GI007 trial-in-progress: Phase I study of OBP-301 (Telomelysin) and definitive chemoradiation (CRT) for patients with locally advanced esophageal and gastroesophageal adenocarcinoma who are not candidates for surgery Meeting Abstract

  

Authors:	Ku, G. Y.; Winter, K. A.; Williams, T. M.; Adusumilli, P. S.; Nishimura, M.; Yock, A.; Ilson, D. H.; Hong, T. S.
Abstract Title:	NRG Oncology NRG-GI007 trial-in-progress: Phase I study of OBP-301 (Telomelysin) and definitive chemoradiation (CRT) for patients with locally advanced esophageal and gastroesophageal adenocarcinoma who are not candidates for surgery
Meeting Title:	2021 Gastrointestinal Cancers Symposium (ASCO GI)
Journal Title:	Journal of Clinical Oncology
Volume:	39
Issue:	3
Meeting Dates:	2021 Jan 15-17
Meeting Location:	Virtual
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2021-01-20
Language:	English
ACCESSION:	WOS:000636712800030
DOI:	10.1200/JCO.2021.39.3_suppl.TPS262
PROVIDER:	wos
Notes:	Meeting Abstract: TPS262 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/180911